Skip to main content
WBF What is
brain fog?
Support WBF Take quiz

Test guide Home measurement

Continuous Glucose Monitor: CGM Results and Brain Fog

A CGM can show the sensor reading before and during brain fog or shaking. Write down the symptom time, meals, activity, sleep, and medicine. Use a finger-stick test when your device or care plan says to confirm an unexpected reading.

Sensor Estimates interstitial glucose every few minutes. Report Read wear time, lows, time in range, highs, and repeats together. What to save Save symptom time beside meals, activity, sleep, illness, and medicines.
01

What a CGM can show

A CGM can show what the sensor read before, during, and after brain fog. You can then check whether the same timing happens again. One low or high reading may be wrong. Repeated matching readings tell you more about whether glucose may have played a part. Look for repeats instead of blaming one food or one night.

Timing

It shows what happened around the symptom

A blood test gives one reading. A CGM shows whether the sensor reading stayed steady, rose, fell, went low, or went high before and during the symptom.

Diabetes care

It shows changes that A1C can't show

Two people can have the same A1C but spend different amounts of time low, in range, or high. A CGM shows those day-to-day changes.

Limits

Use standard tests for a diagnosis

Sensor problems or pressure on the sensor can cause a false low. Glucose often rises after a meal. A steady report still leaves sleep, migraine, medicine, anemia, thyroid, and other causes of brain fog to check.

Compare the report with symptoms and confirm unexpected lows

Use the CGM to record readings over time and support your diabetes plan. A diagnosis needs blood tests, symptoms, and checks for other causes.

Save this test

Save the CGM report with meals, symptoms, sleep, and activity

Save the report with the symptom time, meals, sleep, activity, and medicine. The full record is more useful than one high or low screenshot.

Keep following insulin and medicine instructions until your care team reviews the saved readings.

02

How do age, sex, pregnancy, and treatment affect the readings?

There's no separate CGM range for men and women. Diabetes type, pregnancy, medicine, risk of lows, age, and the reason for wearing the sensor matter more.

Adults with diabetes

CGM is mainly used to manage diabetes. The 2026 ADA standard recommends it for people who use insulin, take medicine that can cause lows, or need it for another treatment plan. Safe use includes training, a backup glucose meter, and a personal plan.

Adults without diabetes

A store-bought sensor can show how readings change around meals and activity. There's no single CGM target for healthy adults. A doctor needs standard blood tests to diagnose diabetes or low blood sugar. Decide what question you want the sensor to answer.

Children and teenagers

Children need a device cleared for their age, simple training, and a plan for home and school. A clinician should set what to do for alerts. Some prescription devices start at age 2, but not every device fits every child.

Pregnancy

Pregnancy uses tighter glucose targets and needs quick care. A CGM may help manage diabetes during pregnancy. Follow the pregnancy and diabetes plan, including blood tests and targets before and after meals.

Menstrual and hormone changes

Save dates when readings or brain fog change with the menstrual cycle, recovery after birth, menopause, hormone medicine, steroids, weight, or activity. These dates can help explain a change in the report.

Older adults

CGM can find lows and make care easier for some older adults with diabetes. The device must fit the person's sight, hearing, hand use, memory, phone skills, home, and support. A caregiver may need access, but the person wearing it should help choose the plan.

03

Before and after the sensor goes on

Know why you're wearing the sensor. The reason may be diabetes care, medicine safety, possible lows, pregnancy care, or a short check of meals and activity.

Follow the instructions for your exact device. Check how to place, start, scan, calibrate, shower with, exercise with, and replace the sensor.

If the device uses a phone, test Bluetooth, alerts, sound, focus mode, and the app. Test them again after phone, headphone, or car-audio changes.

Keep a blood glucose meter and fresh strips if your care plan tells you to confirm readings. Know what to do for a low, a high, or a reading that doesn't match how you feel.

Live as usual during a short review unless your clinician says otherwise. Do not binge sugar, fast, skip medicine, or overexercise just to change the report.

Choose a normal week when you can. Travel, illness, steroids, poor sleep, hard training, alcohol, or menstrual changes can affect the readings.

01

Read the whole report

Check wear time, missing data, average glucose, time in range, time low, time high, and day-to-day repeats. One peak or dip isn't enough to judge the result.

02

Check readings around symptoms

Mark the time of symptoms, meals, activity, sleep, alcohol, illness, and medicine. Check the readings before, during, and after the symptom.

03

Confirm readings that don't match symptoms

Sensor glucose can differ from blood glucose during fast changes or a device problem. Use a finger-stick check when the device or your care plan says to, especially when the reading and symptoms don't match.

04

How to read CGM results

Check there's enough usable data, then read lows, time in range, highs, and symptom timing. The report range must match the person and the reason for wearing the device.

Mostly inside the chosen range

Most readings inside the clinician-set range, with enough usable data to interpret

Glucose stayed mostly inside the chosen range while you wore the sensor. The sensor may still miss brief changes. Sleep, medicine, migraine, anemia, thyroid problems, or another cause may still explain your symptoms.

A repeated change needs checking

Repeated rises, falls, or symptom-linked changes that need confirmation and context

Check if the same change happens on more than one day. Compare it with meals, activity, sleep, illness, alcohol, medicine, pressure on the sensor, and missing data.

Lows, highs, or urgent symptoms need action

Repeated time below or above the clinician-set range, especially readings below 54 mg/dL or urgent symptoms

For a person with diabetes, this may change the safety or treatment plan. Follow the device and diabetes plan. Without diabetes, a doctor must confirm the reading before calling it low or high blood sugar.

A low on the sensor may not be a low in the blood

Pressure during sleep, rapid change, calibration, placement, warm-up, or device problems can produce a misleading reading. If the number doesn't fit how you feel, confirm it as the device and care plan say to.

See research details

Targets can differ for pregnancy, children, older adults, people without diabetes, and people at high risk of lows.

SourceCheck there's enough data first ContextThe international consensus recommends reviewing 14 days of CGM data with at least 70% of data available for many routine diabetes decisions. You may need more days when lows are rare or the readings swing widely.

Check wear time and missing sections before trusting the percentages. A week with long gaps can give a neat report and a weak answer.

SourceThe common diabetes range ContextFor many adults with type 1 or type 2 diabetes, the 2019 consensus defines time in range as 70 to 180 mg/dL. A common goal is more than 70% in that range, less than 4% below 70 mg/dL, and less than 1% below 54 mg/dL.

These targets are for managing diabetes. They don't define normal for everyone who wears an over-the-counter sensor.

SourcePregnancy uses different targets ContextThe international consensus uses 63 to 140 mg/dL for time in range during type 1 diabetes pregnancy. ADA 2026 says CGM can help achieve glucose and A1C goals in type 1 diabetes pregnancy and may help in other forms of diabetes in pregnancy.

A general adult range doesn't apply in pregnancy care. Use the pregnancy and diabetes team's targets and confirm how to use the device.

SourceOver-the-counter doesn't mean for everyone ContextThe FDA's first over-the-counter clearance was for people 18 years and older who don't use insulin and don't have problematic low blood sugar. Each sensor can be worn for up to 15 days, and the app shows readings and trends every 15 minutes. In June 2026, the FDA cleared Stelo for people age 2 or older who don't use insulin. An adult caregiver must supervise children. Stelo doesn't give low-glucose alerts and isn't meant for people with problematic low blood sugar or people on dialysis.

Check the exact label for the device you bought. Do not use an over-the-counter product outside its safety limits because another CGM has different features.

SourceA sensor low isn't the diagnosis ContextA 2025 review says CGM can help correlate symptoms with glucose in adults without diabetes, but compression, calibration, placement, and other errors can create false lows. Diagnosis of hypoglycemia still depends on Whipple's triad and plasma glucose context.

Save the symptom time and confirm unexpected or mismatched readings as directed. Do not build a hypoglycemia diagnosis from silent overnight dips alone.

SourcePrevention evidence is promising, not settled ContextA scoping review published online in 2025 found 12 studies of CGM or flash-monitoring interventions with 1,144 participants, including 353 adults considered at risk for type 2 diabetes. The authors found promise for behavior change but called for stronger studies on long-term acceptability and effectiveness.

Use a short trace to test a practical question, not to create a lifelong food rule or treat the sensor as proof of future health.

SourceOlder-adult usability is not fully answered ContextA systematic review searched 118 titles, reviewed 58 full texts, and included seven studies of adults 60 years or older with type 2 diabetes. Clinical results and satisfaction often favored CGM, but the overall usability assessment was inconclusive.

Weigh vision, hearing, hand use, memory, phone skills, alert burden, cost, skin, and caregiver support when deciding on a device.

SourcePhone alerts need checking ContextIn 2025, FDA warned that notification settings, focus mode, connected audio, app behavior, and unsupported operating-system updates can prevent critical diabetes-device alerts from being delivered or heard.

Test the alert after setup and after phone or accessory changes. A silent phone isn't proof that glucose stayed safe.

05

Safe changes to test while you wear a CGM

Use the report to test one or two safe changes. Glucose naturally rises and falls, so not every change needs a response.

Keep one clean timing log

Save the times of meals, activity, sleep, illness, and symptoms. Mark when your symptoms began, even if you opened the app later. Then you can compare readings before and after symptoms started.

Eat regular, balanced meals without fearing food

If your clinician says food timing is safe to change, eat regular meals and avoid skipping them. Pair carbohydrate foods with fiber and protein. Choose water more often than sugary drinks. Test one change at a time.

Check what repeats, not the scariest spike

Save a change that happens after the same meal or activity on several similar days. Label days with poor sleep, illness, alcohol, hard exercise, or a sensor problem before changing your diet.

Protect your relationship with food

A flatter report is no reason to skip meals or keep cutting foods. If checking makes you anxious or afraid to eat, tell your clinician or dietitian. Keep following any diabetes safety plan while you get help.

Where self-tracking stops

This page isn't a reason to change insulin or another diabetes medicine. Follow the device label and your diabetes or pregnancy plan. Confirm a reading that doesn't match your symptoms. Get medical help when the problem is severe or keeps happening.

06

What to save in My Fog

Keep these together

  • Device, model, prescription or store-bought, and why you wore it.
  • Wear dates, usable-data percentage, report range, and sensor problems.
  • Average glucose, time below range, time in range, time above range, and the times lows or highs repeated.
  • Finger-stick checks and whether symptoms matched the sensor.
  • Meal, activity, sleep, illness, alcohol, menstrual or pregnancy details, and medicine times.
  • The exact brain-fog moment: what you were doing, what you couldn't do, and how long it lasted.
  • What changed during the wear period and what happened on a repeat sensor.

Question for the visit

“Can we compare this report with my symptoms? Does it change my diabetes plan or point to another cause of brain fog? Do I need an A1C, blood glucose test, or review for low blood sugar?”
07

Sources for Continuous Glucose Monitor (CGM)

01
NIDDK

CGM mechanism, interstitial readings, device types, pediatric use, sensor replacement, and finger-stick confirmation.

02
U.S. FDA

First OTC CGM clearance, age, insulin and hypoglycemia limits, 15-day wear, and 15-minute display interval.

03
U.S. FDA

2025 safety warning about missed smartphone alerts and settings checks.

04
CDC

Regular balanced meals and pairing carbohydrate foods with protein, fat, or fiber.

05
CDC

Blood-glucose self-management, regular meals, avoiding skipped meals, activity, and drink choices.

06
ADA Standards of Care, 2026

Prediabetes and diabetes diagnosis, including the limit on CGM for screening and diagnosis.

07
ADA Standards of Care, 2026

CGM and glucose targets in diabetes during pregnancy.

08
ADA Standards of Care, 2026

CGM use, hypoglycemia risk, treatment burden, cognition, and support in older adults.

09
ADA Standards of Care, 2026

Diabetes distress, disordered eating, and avoiding rigid or harmful monitoring behaviors.

10
ADA Professional Practice Committee, 2026

Current diabetes-technology standards, training, backup meter access, children, adults, pregnancy, and individualized device use.

11
Battelino et al., 2019

International consensus on 14-day data sufficiency, time in range, low thresholds, pregnancy range, and individualized targets.

12
Amoh et al., 2026 (online 2025)

Scoping review of CGM and flash monitoring interventions in adults at risk for type 2 diabetes.

13
Arriazola et al., 2025

Review of prescription and over-the-counter wearable glucose sensors.

14
Savoy et al., 2026

Systematic review of CGM effectiveness, satisfaction, and usability in older adults with type 2 diabetes.

15
Cryer et al., 2009

Endocrine Society guideline on Whipple's triad and adult hypoglycemia evaluation.

16
Looi and Lawler, 2025

Adult non-diabetic hypoglycemia review, CGM false-low limits, confirmation, and Whipple's triad.

17
FDA: Stelo clearance for children, June 2026

Stelo age-2 indication, non-insulin use, caregiver supervision, device alerts, sensor wear and app readings.

See each claim's sources

procedure

For many routine diabetes reviews, the international consensus recommends 14 days of CGM data with at least 70% of possible data available.

range

For many adults with type 1 or type 2 diabetes, consensus targets define time in range as 70 to 180 mg/dL, with more than 70% in range, less than 4% below 70 mg/dL, and less than 1% below 54 mg/dL.

limitation

ADA 2026 says evidence is insufficient to use CGM for screening or diagnosis of prediabetes or diabetes; diagnosis uses A1C or plasma-glucose criteria with confirmation when required.

safety

In June 2026, the FDA cleared Stelo for people age 2 or older who don't use insulin. An adult caregiver must supervise children. Stelo doesn't give low-glucose alerts and isn't meant for people with problematic low blood sugar or people on dialysis. Each sensor can be worn for up to 15 days, and the app presents readings and trends every 15 minutes.

limitation

CGM may help align symptoms with readings, but adults without diabetes still need Whipple's triad and plasma-glucose context to diagnose hypoglycemia, because false lows can occur.

safety

FDA warned in 2025 that phone notification settings, focus mode, connected audio, app behavior, and unsupported operating-system updates can prevent diabetes-device alerts from being delivered or heard.

context

A 2025 scoping review found 12 studies of CGM or flash-monitoring interventions with 1,144 participants, including 353 at-risk adults, and concluded that the approach showed promise while stronger long-term studies were still needed.

context

A 2026 systematic review screened 118 titles, reviewed 58 full texts, and included seven studies of adults 60 years or older with type 2 diabetes; clinical effectiveness was supported but usability remained inconclusive.

context

CGM can help achieve glucose and A1C goals in type 1 diabetes pregnancy and may help other diabetes types in pregnancy, using pregnancy-specific targets rather than general adult targets.

diet

CDC diabetes guidance supports regular balanced meals, avoiding skipped meals, pairing carbohydrate foods with protein, fat, or fiber, and choosing water over sugary drinks as practical blood-glucose management steps.